HIGHLIGHTS
- who: Luis M. A. Oliveira from the Institut University Tübingen, Tübingen, Germany have published the article: Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease, in the Journal: Neurology, of 24/Dec/2020
- what: The lack of antibodies that specifically recognize these PTMs, and their low abundance in the brain have hampered further studies aimed at elucidating their role in PD and other synucleinopathies. The majority of aSyn PTMs were identified in studies aimed at investigating aSyn pathology in human brains or in mouse models of PD. The dynamic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.